Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.

NACompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

February 19, 2021

Study Completion Date

February 19, 2021

Conditions
Bacteremia SepsisFungemia
Interventions
DIAGNOSTIC_TEST

Multiplex PCR

Quick adaptation of antibiotic treatment according to the species identified and to the results of the resistance markers present in the multiplex PCR

DIAGNOSTIC_TEST

Current strategy alone

Identification of bacteria and micromyces isolated in blood cultures after subculture by mass spectrometry (MALDI-TOF) and determination of their sensitivity to antibiotics or antifungals by antibiotic susceptibility testing or antifungigram

Trial Locations (1)

38043

Grenoble University Hospital, Grenoble

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GenMark Diagnostics

INDUSTRY

lead

University Hospital, Grenoble

OTHER